Dr. Schreiber joined EXUMA Biotech in April 2016 and currently serves as its Vice President of Intellectual Property & Licensing. In his previous leadership roles over the past two decades at Intrexon Corporation, Thermo Fisher Scientific, and Johns Hopkins University, he led the licensing efforts that formed the basis of more than a dozen commercial products.
Dr. Schreiber received his B.A. in biochemistry from the University of California, Berkeley and his Ph.D. in immunology from Washington University in St. Louis. Additionally, he is registered to practice before the U.S. Patent and Trademark Office.